Prompt elimination of pathogens including bacteria and dead cells prevents the expansion of secondary and prolonged inflammations and tissue damage. Keigairengyoto (KRT) is a traditional Japanese medicine prescribed for dermatoses such as purulent inflammations. Our aim is to clarify the actions of KRT in bacterial clearance and to examine the cell-kinetic profiles of phagocytes. In a mouse cutaneous infection model using living Staphylococcus aureus, KRT drastically reduced the number of bacteria in the infection sites. To evaluate the bacterial clearance, pseudo-infection was induced in mouse ears by intradermal injection of FITC-conjugated dead S. aureus. Biochemical and histological examinations revealed that KRT promoted bacterial clearance at 6 and 24 h post-injection. The numbers and phagocytic activities of neutrophils and macrophages in the ears were evaluated histologically using anti-Ly6G and F4/80 antibodies. KRT reduced bacterial deposition and increased the accumulation of F4/80 + resident macrophages around the lesion site. FACS analysis was performed on single cell suspensions dispersed enzymatically from skin lesions, followed by an investigation of CD11b + Ly6G + (neutrophils) and CD11b + Ly6G -(monocytes/macrophages) cells. KRT increased the mean fluorescent intensity of FITC in CD11b 
Introduction
The skin functions as a barrier to pathogens such as bacteria. In injured skin or immunosuppressive conditions, bacteria can enter the body, leading to infectious inflammation. Chronic stimulation by bacteria can cause skin inflammation, and dysregulated responses to infection can induce life-threatening septic shock. Innate immune cells possess receptors for pathogen-associated molecular patterns (PAMPs) and eliminate foreign invaders [1] . Prompt, flexible, and appropriate clearance of PAMPs is important to prevent the expansion of excessive inflammatory reactions and prolonged inflammations.
Professional phagocytes, such as neutrophils, macrophages, and dendritic cells, play roles to eliminate harmful and/or inflammatory particles. Circulating neutrophils are rapidly recruited to infectious areas through chemotactic signals [2] . Neutrophils dominantly express va rious receptors for PAMPs and bear the primary defense against infection by killing bacteria through some bactericidal mechanisms [3] . Macrophages and dendritic cells are residents in the skin and function as sentinel cells in the body's first line of defense against microbes as well as neutrophils [4, 5] . Macrophages have various types of receptors for PAMPs and manage the innate immune system, while dendritic cells are the key cells in the development of acquired immune system as antigenpresenting cells. Macrophages have characteristics of diversity and plasticity in cell differentiation, therefore playing roles in inflammation and tissue repair and regeneration [6] . Resident dermal macrophages orchestrate the initiation and termination of immune response in skin infection [7] . A deficiency of macrophage function fails in the timely recruitment of neutrophils to the site of infection and delays bacterial clearance [7] . These lines indicate that resident dermal macrophages play important roles in the initial detection of skin-infiltrating bacteria and the activation of neutrophils.
Keigairengyoto (KRT) is a pharmaceutical grade traditional Japanese (kampo) medicine that is prescribed to patients with purulent dermatoses, which generate many dead neutrophils, followed by non-infectious inflammation. KRT is also prescribed to ameliorate purulent inflammation in other organs, such as empyema and rhinitis. KRT comprises 17 crude drugs and abundantly includes flavonoids, some of which enhance the phagocytic activity of myeloid leukemia cells and activate macrophage-like cells [8] [9] [10] [11] [12] . Genistein, which is rich in Glycyrrhizae radix, is reported to modify macrophage differentiation [13, 14] , inhibit LPS-induced downregulation of monocyte chemotactic protein-1(MCP-1) receptors, and promote the potentials of skin tissue repair [15] [16] [17] . Given that KRT is clinically effective against purulent inflammation in humans, these reports suggest that KRT enhances macrophage function. We therefore hypothesized that KRT activates innate immune response and promotes elimination of bacteria. As the skin resident bacterium Staphylococcus aureus is involved in skin diseases, such as impetigo and cellulitis, we evaluated the effects of KRT in mouse infection models using S. aureus. As expected, KRT markedly reduced the number of living S. aureus in the site of infection. We also examined the cell-kinetic profiles of neutrophils and macrophages in a pseudo-infection model using FITC-conjugated dead S. aureus and we observed KRT-enhanced bacterial clearance through modification of the immune system.
Materials and methods

Test drugs
KRT was supplied by Tsumura & Co. (Tokyo, Japan) in the form of a powdered extract. It was obtained by spray-drying a hot-water extract mixture of the following 17 crude drugs: Scutellariae radix, Phellodendri cortex, Coptidisrhizoma, Platycodi radix, Aurantiifructusimmaturus, Schizonepetaespica, Bupleuri radix, Gardeniae fructus, Rehmanniae radix, Paeoniae radix, Cnidiirhizoma, Angelicae radix, Menthaeherba, Angelicaedahuricae radix, Saposhnikoviae radix, Forsythiaefructus, and Glycyrrhizae radix.
Many papers demonstrated that the commonly used and effective dose of kampo medicines is approximately 1 g/kg body weight in animal experiments including in dermatitis study [18, 19] . Plasma pharmacokinetic study of bioactive fla vonoids, which are speculated as active cons tituents of KRT, showed that they are absorbed promptly and transiently into the systemic circu lation [18] . In order to examine the preventive effect of KRT, we administrated KRT at 0.25-2 g/kg body weight 1 h before and after cutaneous stimulation.
Prednisolone sodium succinate (PDN) was purchased from Shionogi Pharmaceutical Co. (Osaka, Japan) and used as a reference drug. Genistein 7-O-glucuronide and hesperetin 7-O-glucuronide were purchased from Toronto Research Chemical Industries (Toronto, ON, Canada). Liquiritigenin 4'-O-glucuronide, liquiritigenin 7-O-glucuronide, 18β-glycyrrhetinic acid, and cimifugin with purities high enough to be evaluated in biological tests were obtained from Analytical and Pharmaceutical Technology Research Center, Tsumura & Co. These compounds are absorbed through the digestive system and detected in the systemic circulation of humans and rats [18, 20] .
Animals
Male BALB/c and ICR mice were purchased from Japan SLC Inc. (Shizuoka, Japan) and Charles River Laboratories Japan Inc. (Kanagawa, Japan), respectively. Each mouse was used at 8-10 weeks old. This study was approved by and conducted according to the guidelines of the Experimental Animal Ethics Committees of Tsumura & Co.
Superficial skin infection model
Living S. aureus-induced cutaneous infection was performed in BALB/c mice according to the procedure described by Kugelberg et al. with a minor modification [21] . The hair on the back was shaved with an electric razor and depilatory cream under ketamine anesthesia was applied. An area of approximately 4 cm 2 was stripped with clothmade cohesive tape once a day for two days. After the stripping in the second day, S. aureus MW2 (strain: BAA-1707, ATCC, Manassas, VA, USA) was inoculated on the skin at 1 × 10 7 colony forming unit (CFU) in 100 μL saline. KRT was administrated orally to the mice at 1 and 2 g/kg in distilled water 1 h before and 1, 2, and 3 days after the inoculation. Skin lesion was examined at days 2 and 4 after the inoculation. The severities of erosion and papule were scored according to the following criteria: 0 (none), 1 (mild), 2 (moderate), and 3 (severe), and were indicated as the sum of each score. Mice were sacrificed by exsanguination under anesthesia at day 4 after the inoculation, and the skin of the infected site was excised and homogenized in saline. The homogenates were plated on staphylococcus agar to determine the number of living bacteria. The number of living bacteria was indicated as CFU per weight of the skin tissues (CFU/g).
Pseudo-infection model
Pseudo-infection model was performed in ICR mice using FITC-conjugated bioparticles of heat-or chemically-killed S. aureus, which were purchased from Thermo Fisher Scientific Inc. (Waltham, MA, USA). FITC-conjugated S. aureus (2 × 10 7 particles in 10 μL saline) or saline alone was intradermally injected into the ventral side of both ears using a microsyringe (Hamilton Co., Reno, NV, USA) under isoflurane anesthesia. KRT was administrated orally to the mice at 0.25 and 1 g/kg in distilled water 1 h before and 6 h after the injection. PDN was administrated orally to the mice at a dose of 10 mg/kg in distilled water. The mice were sacrificed by exsanguination under anesthesia 2, 6, or 24 h after the injection, and the ears were cut off for the following examinations.
Measurement of bacterial clearance
Bacterial clearance from the infected ears was evaluated by two methods. First, the ears were immersed in 1 N KOH and lysed completely, followed by the measurement of fluorescent inten sity at an excitation wavelength of 495 nm and an emission wavelength of 528 nm. The amount of bacteria was calculated using a standard curve of serially diluted FITC-conjugated S. aureus. In the second method, the ears were stained by Gram's method as described in the next section, and the depositions of Gramstained bacteria were semi-quantified by image analysis using BZ-X analyzer software (Keyence, Osaka, Japan).
Histological evaluation
The back skin and the ears were fixed with 10% formaldehyde and 4% paraformaldehyde, respectively. The fixed tissues were embedded in paraffin and cut into 4-μm cross-sections. The specimens were stained with hematoxylin and eosin (HE) or Gram-Hacker's solution. For immunofluorescent analysis, sections were stained using 2 μg/mL of antimouse F4/80 (clone: A3-1, Bio-Rad Laboratories Inc., Hercules, CA, USA) and 1 μg/mL of Alexa 647-conjugated anti-rat IgG2b (Thermo Fisher Scientific Inc.), or 2 μg/mL of biotin-conjugated anti-mouse Ly6G (clone: 1A8, BioLegend, San Diego, CA, USA) and 0.1 μg/mL of APC-conjugated streptavidin (BioLegend), and then mounted using ProLong Gold Antifade Reagent with DAPI (Thermo Fisher Scientific). All images were taken using a Biorevo BZ-X700 fluorescence microscope and BZ-X viewer software ( 
Measurement of chemokines and cytokines in inflamed ears
The ears obtained at 1 h after the S. aureus injection were frozen immediately in liquid nitrogen, and then were crushed using a cryopress machine (Microtec Co., Chiba, Japan). The crushed ears were homogenized in cold PBS supplemented with a cocktail of proteinase inhibitors (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged at 10,000 g for 15 min at 4 °C. MCP-1, interleukin-1β (IL-1β), and keratinocyte chemoattractant (KC) in the supernatant of homogenates were quantified using ELISA kits according to the manufacturer's instructions (R&D Biosystems, Minneapolis, MN, USA). Total protein was measured by the Lowry assay (Thermo Fisher Science) using bovine serum albumin as a standard.
Immune cell analysis by flow cytometry
The procedure was performed according to the previous report with a minor modification [7] . The ear was cut into nine pieces, followed by enzyma tic digestion in PBS containing 0.45 mg/ mL dispase I (Roche Diagnostics, Indianapolis, IN, USA), 2 mg/mL collagenase II (Sigma-Aldrich), and 0.32 mg/mL DNase I (Sigma-Aldrich) for 2 h while shaking at 37 °C. Single-cell suspensions were prepared by mechanical disruption in icecold Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS, followed by filtration through a 70-μm cell strainer. After centrifugation twice, the cells were gently suspended in 30% Percoll (GE Healthcare, Piscataway, NJ, USA), and then centrifuged at 630 g for 20 min to isolate and remove sebum, low-density cells and debris. Cell pellets were re-suspended in 10% FBS DMEM and passed through a 40-μm cell strainer. After centrifugation, the cells were fixed with paraformaldehyde and stored at 4 °C until flow cytometric analysis. After blocking nonspecific binding using mouse IgG1 (clone MG1-45, BioLegend), the following antibodies to mouse antigens were used: PE anti-mouse CD45 (clone: 30-F11, BD Bioscience, San Diego, CA, USA), PE/ Cy7 anti-CD11b (clone: 30-F11, BioLegend), and biotin anti-Ly6G (clone: 1A8, BioLegend). APCconjugated streptavidin was used for the secondary reagents. Cell samples were analyzed with a twolaser flow cytometer FACSaria II, and the data were analyzed with Diva software version 8. 
Measurement of ear thickness
Ear thickness was measured using a dial thickness gauge micrometer (Ozaki MFG Co., Tokyo, Japan), at 0, 2, 6, and 24 h after the injection of FITCconjugated S. aureus in mice under isoflurane anesthesia. All data on the increase in ear thickness were expressed as a percentage of the previous value in each individual mouse.
Macrophage culture assay
Cells of mouse macrophage cell line RAW264.7 (ATCC, Manassas, VA, USA) were grown in DMEM supplemented with 10% FBS, 4.5 g/L glucose, 2 mmol/L L-glutamine, 100 U/mL penicillin, 100 µg/ mL streptomycin, and 10 mmol/L HEPES. Cells were seeded in 96-well culture plates at 5 × 10 3 cells/ well, and cultured with the test compound (30 μmol/ L) in the presence or absence of the suboptimal-dose 0.5 ng/mL mouse interferon-γ (IFN-γ) (PeproTech Inc., Rocky Hill, NJ, USA). After 3 days of incubation at 37 °C, culture fluids were removed and FITC-conjugated S. aureus at 30 μg/mL in warm medium was added. After 30-min incubation in a 5% CO 2 incubator, cells were harvested using cold PBS containing 2 mmol/L EDTA, then washed and treated for 15 min at 4 °C with phosphate buffer containing 4% paraformaldehyde (pH 7.4). FITC-positive cells were determined using a FACSaria II flow cytometer and DIVA 8.0.1 software. Activity was indicated as the MFI of whole cells.
Definition of group names and statistical analysis
A mouse not treated with S. aureus was defined as "normal", and a mouse treated with S. aureus alone (no KRT) was defined as a "control". The 0.25, 1, and 2 g/kg of KRT were described as KRT-L, KRT-M, and KRT-H, respectively. All values are expressed as mean ± SEM. Student's t-test was performed to compare normal and control groups. Tukey's, Tukey-Kramer, Steel's, Steel-Dwass, and Dunnett's tests were used to perform multiple comparisons between groups, or between control groups and drug-administered groups. A probability of <0.05 was considered significant.
Results
KRT reduces the number of living S. aureus in the cutaneous infection
We first investigated the effects of KRT on superficial skin infection model. The number of living bacteria in control mice was 726.3 ± 155.6 (× 10 5 CFU/g) at 4 days post the inoculation ( Figure 1A) . KRT-M (1 g/kg) and KRT-H (2 g/kg) dramatically reduced the number of living bacteria to 6.2 ± 0.4 and 3.5 ± 1.1 (× 10 5 CFU/g), respectively. Macroscopic lesion scores at 2 and 4 days were lower in mice treated with KRT-M or KRT-H than the control mice ( Figure 1B) . Representative macro scopic images are shown in Figure 1C . An exten sive erosion with severe crust formation was observed in the back skin of control mice at day 2. In contrast, those of the mice treated with KRT-M and KRT-H showed milder skin lesion with less erosion and crust formation, and erosions and papules were hardly observed in KRT-H-treated mice at day 4. Histological observation revealed that KRT suppressed acanthosis and spongiosis in epidermis and edema in dermis ( Figure 1D) .The quantitative analysis of histological observations results are shown in Supplementary Figure S1 .
KRT augments clearance of S. aureus
In order to focus on action of bacterial clearance, we next examined the effects of KRT in pseudoinfection model using FITC-conjugated dead S. aureus. We first examined, on whether KRT accelerates bacterial clearance, by measuring the amount of remaining FITC-conjugated S. aureus in the ear (Figure 2A) . The amount of bacteria in control mice was above 200 µg/ear at 2 h post-S. aureus injection and gradually decreased to less than half by 24 h. KRT-M significantly decreases the amount of bacteria at 6 and 24 h post-injection, though it shows no difference at 2 h. PDN exhibited no difference from the control at any time point. We histologically evaluated the bacterial clearance at 6 h post-injection in Gram-stained specimens. In control mice, gram-positive bacteria were deposited in the dermis of the ears ( Figure 2B) . KRT-M significantly decreased the deposition of gram-positive bacteria (Figures 2B and 2C) . In contrast, PDN exhibited no difference from control. These findings indicated that KRT promoted bacterial clearance. After tape stripping from the back skin of mice, S. aureus was inoculated at 1 × 10 7 CFU in 100 μL. Keigairengyoto (KRT, 1 and 2 g/kg) suspended in distilled water was administered orally to mice at 1 h before and 1, 2, and 3 days after the inoculation. The back skins were excised from mice on day 4. The number of living bacteria was measured on day 4 (A). Macroscopic damage scores of the infection sites were evaluated on day 2 and 4 (B and C). The skin sections on day 4 were stained with hematoxylin and eosin staining. Representative images are shown as low-power (upper panels) and high-power (lower panels); green boxes: the sites of each magnification; arrows: pustule; arrowheads: spongiosis; black bars: 200 μm; and yellow bars: 50 μm (D). N = 2 (normal) or 6 (control, KRT-M, and KRT-H). **: P < 0.01; *: P < 0.05 (Steel's test).
KRT reduces FITC-positive signals in clumps of S. aureus
Neutrophils were visualized as Ly6G
+ cells by fluorescent staining, and the localization of Ly6G + cells in clumps of FITC-conjugated bacteria was observed (Figure 3) . In control mice, Ly6G
+ cells (red fluorescence) infiltrated mildly around the clumps of bacteria (green fluorescence) at 2 h, the cell infiltration had increased at 6 h, and an abscess had formed in the dermis with a decrease in FITCconjugated bacteria at 24 h. In KRT-M-treated mice at 6 h, Ly6G FITC-conjugated bioparticles of killed S. aureus were injected into both ears at 2 × 10 7 particles/10 μL/site. The ears were cut off at 2, 6, and 24 h after injection. Keigairengyoto (0.25 and 1 g/kg) suspended in distilled water or prednisolone (10 mg/kg) was administered orally to mice at 1 h before and 6 h after the injection. The amount of bacteria in the ears was measured biochemically at 2, 6, and 24 h after the injection (A). The ear sections were stained with Gram-Hacker's solution (B) and the deposition of Gram-positive bacteria in the lesion area was measured at 6 h after injection by an image-analysis technique (C). Yellow bars indicate 50 μm. N = 8. **: P < 0.01 (Tukey's test); #: P < 0.05 (Dunnett's test).
lesions revealed no remarkable difference between groups at 6 h (data not shown). These results suggested that KRT treatment enhanced neutrophil penetration into the bacterial clumps at certain time periods, but did not significantly increase neutrophil numbers in the lesion.
KRT accelerates accumulation of macrophage-like cells around clump of S. aureus
HE-staining images at 6 h after the bacterial injection are shown in Figure 4 . In normal mice without bacteria injection, resident macrophageswhich had mononuclear morphology and larger cell size than resident lymphocytes-are observed. Macrophages-like cells, as well as polynucleated neutrophils, accumulated to the dermis around the bacteria clump in control mice at 6 h. In mice treated with KRT-M, the frequency of macrophages-like cells around the bacteria clumps was higher than control and showed larger abscesses at 6 h postinjection. Mice treated with PDN did not show a remarkable difference in macrophage-like cell infiltration compared with control mice.
KRT enhances F4/80 + cell accumulation to the lesion
To clarify the cell-type of macrophage-like cells observed in Figure 4 , fluorescent staining using anti-F4/80 antibody was performed. F4/80 protein is expressed mainly in resident macrophages, while monocytes also express it at a lower level than macrophages. F4/80 + -resident macrophages were observed in the dermis of normal mice, as shown in Figure 5A . F4/80 + cells were accumulated around the bacteria clumps in control mice at 2 h after the bacterial injection. Mice treated with KRT-M showed more accumulation of F4/80 + cells compared with the control, and this was confirmed by counting the number of F4/80 + cells per unit area around the lesion site ( Figure 5B) . PDN-treated mice showed Next, we investigated whether KRT affects the production of chemokines and cytokines related to macrophage functions. As KRT enhanced F4/80 + cell accumulation compared to controls as early as 2 h, we examined the chemokine and cytokine production in the ears at 1 h after bacteria inoculation. KRT-M, however, showed no difference in the production of KC, MCP-1, and IL-1β at 1 h after the injection (Figure 6 ). We also measured them at 6 h postinjection and observed that KRT treatment did not alter the expression of these chemokines in the lesion (data not shown).
KRT augments phagocytosis by infiltrated cells in vivo
To quantitate numbers, populations, and phagocytic activity of macrophages and neutrophils in the lesions, FACS analysis was performed at 6 h after the S. aureus inoculation. In this study, CD11b + Ly6G -and CD11b + Ly6G + cells were designated as monocyte/macrophages and neutrophils, respectively. There was no change in the number of CD11b + Ly6G -cells among the groups of normal, control, and KRT-treated mice. In contrast, the number of CD11b + Ly6G + cells had clearly increased in the control group at 6 h after the injection compared to the normal group, but the difference between control and KRT-M-treated groups was not significant ( 
KRT suppresses ear swelling due to S. aureus ino culation
It generally is thought that the activation of innate immune cells may exacerbate inflammatory symptoms. Therefore, we examined the effect of KRT on ear thickness (Figure 7) . At 2, 6, and 24 h after the injection, the ear thickness of control mice had increased 1.7, 2.4, and 2.9 times compared with that of normal mice, respectively. We did not observe remarkable differences in ear swelling between control and KRT-M at 2 h after bacteria inoculation or abscess formation (Supplementary Figure  S3) . Of note, KRT-M significantly suppressed the increase in ear thickness at 6 h, though mice treated with KRT-M showed larger abscesses at 6 h postinjection, as shown in Figure 4 . At 24 h, mice treated with KRT-M showed significantly thinner ears and smaller abscesses than control mice (Supplementary Figure S3) . PDN also significantly suppressed ear swelling as well as abscess formation by S. aureus inoculation at all time points.
Active compounds of KRT augment phagocytosis by macrophages in vitro
Finally, we examined whether absorbed compounds related to KRT can augment macrophage functions in vitro. As shown in Table 2 , genistein 7-O-glucuronide remarkably enhanced phagocytic activity in the macrophage cell line RAW264.7.
Liquiritigenin 7-O-glucuronide also promoted pha gocytosis by RAW264.7, while liquiritigenin 4'-O-glucuronide, hesperetin 7-O-glucuronide, 18β-glycyrrhetinic acid, and cimifugin were inactive in the present test.
Discussion
In this study, we demonstrated that KRT decreased the number of living bacteria and suppressed the development of the bacteria-induced skin lesions (Figure 1) . Furthermore, we observed in the pseudoinfection model that KRT significantly decreased the numbers of dead bacteria at 6 and 24 h post-injection by measuring FTTC-signals in the homogenizations of the inflamed ears (Figure 2A) . As a complementary test, the histological examination by Gram- Keigairengyoto suspended in water was given orally to mice at a dose of 1 g/10 mL/kg, and 1 h later, FITC-conjugated S. aureus was injected to the ears. The ears were removed 6 h post-injection, and single cells were prepared by an enzyme-dispersing procedure. Phagocytic cells in the single ear cells were stained by anti-mouse Ly6G and anti-mouse CD11b and analyzed by flow cytometry. Data are shown as mean of 2 (Normal), 6 (Control), and 6 (KRT) ears per a group. Total numbers of harvested ear cells were 293, 322 ± 18, 354 ± 11 × 10 4 , respectively. R1, R2, R3, and R4 indicate each region built in the dot plots of Supplementary Figure S1 . There was no difference among groups. *: P < 0.05 significant with the Student's t-test.
stain indicated that KRT re duced S. aureus per unit lesion area 6 h after the injection ( Figure 2B ). Taken together, it is plausible to conclude that KRT enhances S. aureus clearance from infectious sites.
KRT is reported to have an anti-bacterial activity against S. aureus and Propionibacterium acnes in in vitro assays [22, 23] . Therefore, the result of KRT in the infection model using living S. aureus may be due to direct attack against to the S. aureus. On the other hand, pseudo-infection experiment was performed in order to eliminate a possibility of direct bactericidal effect of KRT. It is plausible to conclude that KRT enhances the potentials of phagocytic cells, such as macrophage and neutrophils, and promotes bacterial clearance. It is unclear how much the enhancing effect of KRT on innate immune cells contributes to reducing the number of living S. aureus in the infection model. However, the enhancing effect of KRT is surely involved at least partially in bacterial clearance in the present infection model. One of the important strategies is to investigate a mechanism by which the bioactive flavonoids shown in Table 2 enhance macrophage functions. We should examine cell-based kinetic study focusing on innate immune cells in the superficial skin infection model to clarify the effect of KRT, as well as the bioactive flavonoids, in more detail.
The histological examinations by HE and immuno staining using anti-F4/80 antibody indicated that KRT augmented resident macrophages accumulation around the clumps of bacteria or lesion site. Interest ingly, KRT did not increase the number of CD11b + Ly6G -cells in FACS analysis, which represented the number of macrophages per ear at 6 h post-injection ( + macrophages around the bacteria clump is supposed to depend on the migration of resident macrophages from the nearby skin but not from the systemic circulation. Moreover, KRT increased phagocytosis by macrophages, which was shown as a higher MFI of FITC conjugated to S. aureus in CD11b
+
Ly6G
-cells than that of control group at 6 h in FACS analysis. FACS analysis performed at 2 h post-injection as well as the 6 h protocols similarly showed that KRT enhanced macrophage functions (data not shown).
Interestingly, our study found that the numbers of F4/80 + cells per area around the lesion site in control groups decreased transiently at 6 h after the bacterial injection and then increased at 24 h, compared with normal groups. It is reported that S. aureus infection induces pyroptosis of resident macrophages, which is a pro-inflammatory programed cell death [24] . Macrophages that died by pyroptosis release alarmins including IL-1β, which induces recruitment and activation of neutrophils [25] . Cell death by pyroptosis is considered to play a crucial role for efficient elimination of bacteria. In an animal model of S. aureus skin infection, F4/80 high dermal macro phages initially decrease post-infection and expand later due to renewal by incoming Ly6C high inflammatory monocytes [7] . Thus, our finding of the transient decrease of F4/80 + cells may relate to the Figure S2) . Although KRT treatment did not increase the number of CD11b + Ly6G + cells in the whole ears compared to the control, FITC-positive CD11b + Ly6G + cells were significantly more numerous in KRT-treated mice than in the control ( Table 1 ). The MFI of FITC in CD11b
+
Ly6G
+ cells, which is a parameter of phagocytic potential per cell, was much higher than that in CD11b + Ly6G -cells. Accordingly, Ly6G + cells were observed more frequently in the clump of FITC-positive S. aureus in the KRT-treated group at 6 h post-injection, and the histological images of FITC-positive S. aureus clumps were evidently fewer in KRT-treated group than that of control group (Figure 3) . Circulating neutrophils are recruited rapidly to infectious areas through chemotactic signals and eliminate bacteria by bactericidal and phagocytic mechanisms [2, 3, 26] . Depletion of neutrophils delays bacterial clearance and causes lethality in mouse lung infection [27] . Considering that neutrophils are the most professional effect or cells against foreign pathogens, the capacity of KRT to promote bactericidal functions of neutrophils should be noted.
Some kampo medicines including KRT are flavonoid-rich. To evaluate the effects of KRT on phagocytosis by macrophage, we investigated the absorbed flavonoid compounds, which would be detected in the blood of mice that were given KRT orally. We recently demonstrated that jumihaidokuto, another kampo medicine that contains the same flavonoid-rich components as KRT, suppresses Propionibacterium acne-induced dermatitis by modulating macrophage function [19] . Considering our pharmacological and blood pharmacokinetic studies of jumihaidokuto [18, 19] , genistein 7-O-glucuronide, liquiritigenin 7-O-glucuronide, liquiritigenin 4'-O-glucuronide, hesperetin 7-O-glucuronide, 18β-glycyrrhetinic acid, and cimifugin were chosen for in vitro assays of macrophage phagocytosis in this study. Among these compounds, genistein 7-O-glucuronide was the most active in enhancement of phagocytosis. We recently clarified that glucuronides of phytoestrogen flavonoids, such as genis tein and liquiritigenin, enhance macrophage functions via de-conjugation and stimulation of nuclear estrogen receptor in macrophages, resulting in the up-regulation of phagocytosis and expressions of complement receptors, Fc-receptors, chemotactic receptor, and so on [28] . Flavonoids of KRT would work directly on the innate immune system in vivo.
Proinflammatory cytokines and toxic radicals produced by activated macrophages would induce inflammatory symptoms such as edema and reddening of the skin. We measured ear thickness as a general clinical marker of skin inflammation after dead bacteria inoculation. To our surprise, al though KRT recruited more macrophages and neutrophils to the bacteria clumps, KRT rather suppressed ear thickness at 6 and 24 h post-injection compared to the control. Histological observation in the infection model of living bacteria revealed that KRT suppressed edema of the epidermis and dermis in the lesion skin ( Figure 1D) . We observed that skin lesions of the KRT-treated group did not show obvious differences in KC, MCP-1 and IL-1β expression compared to the control group at 1 h postinjection (Figure 6 ). IL-1β was also measured at 6 h after the injection, but no difference was observed in KRT-treated mice (data not shown). These indicated that inhibitory effect of KRT on ear thickness did not depend on the modulation of proinflammatory cytokines induction.
KRT-treated mice showed thinner ears at 6 h while the bacteria had not been completely phagocytized and cleared. KRT-treated mice also showed less ear thickness and clearly smaller abscesses than the control at 24 h, suggesting that KRT enhanced the bacteria clearance at this point. PDN, which has strong inhibitory effects on various inflammatory responses, also suppressed ear thickness without affecting bacteria clearance. Therefore, KRT may have mechanisms other than promoting macrophage functions to suppress skin inflammation. In bacteriainfected sites, damaged cells, dead cells, and phago cytes produce toxic radicals. An excessive production of toxic radicals in the extracellular space can damage the surrounding healthy tissues and cause secondary non-infectious inflammation [29, 30] . KRT has many blood-absorbing anti-oxidant constituents [31, 32] . Our previous study demonstrated that liquiritigenin 7-O-glucuronide emerged in blood immediately after oral administration and exerted anti-oxidant activity [18] . Blood pharmacokinetic studies of active compounds originating from KRT could uncover the detailed mechanisms by which KRT exerts anti-inflammatory functions.
Conclusion
This is the first report to confirm that oral administration of KRT promoted bacteria clearance in mice. KRT activated resident macrophages to migrate to the bacteria lumps and promoted phagocytosis against FITC-conjugated S. aureus. In vitro assays showed that absorbed flavonoids such as genistein 7-O-glucuronide remarkably promoted phagocytic activity in a macrophage cell line. Moreover, KRT enhanced the number of FITCpositive neutrophils in the ears, probably through the activation of resident macrophages (Figure 8) . Thus, KRT activated the innate immune system, which was supported by the results in the infectious and pathophysiological model of the living bacteria. 
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